Teladoc Health, Inc. (NYSE: TDOC) is a Healthcare company (Medical - Healthcare Information Services) with a market capitalization of $1.5B. The Maz Rating grades it against the other companies in its sector.
Teladoc Health, Inc.'s current Maz Rating and its five factor grades are for members: log in to see them.
At $8.49, Teladoc Health, Inc. trades at 0.6x sales and 1.2x book value, with an EV/EBITDA of 7.3. Over the last twelve months it generated about $2.5B of revenue and a net loss of $157M. It runs a gross margin of 73.2%, an operating margin of -6.1% and a net margin of -6.3%. It shows return on equity of -11.6%, return on invested capital of -6.2% and a free cash flow yield of 15.0%. On the balance sheet: a debt-to-equity ratio of 0.80 and a current ratio of 0.87. Over the past 52 weeks the share price ranged from $4.40 to $9.89, with a beta of 1.97.
Teladoc Health, Inc. does not currently pay a dividend.
42 Wall Street analyst ratings cover the stock: 15 Buy and 27 Hold, for a Hold consensus. This is the sell side's view, separate from the Maz Rating.
Figures are trailing twelve months unless stated. The Maz Rating and Maz Dividend Score rank a company against its own sector; they are not price targets or recommendations.